• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性调节的激素结合协同作用横跨糖蛋白激素受体同源体的证据。

Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers.

机构信息

IRIBHM, Université Libre de Bruxelles, Campus Erasme, Brussels, Belgium.

出版信息

Nat Commun. 2012;3:1007. doi: 10.1038/ncomms1991.

DOI:10.1038/ncomms1991
PMID:22893131
Abstract

Glycoprotein hormone receptors show strong negative cooperativity. As a consequence, at physiological hormone concentrations, a single agonist binds to a receptor dimer. Here we present evidence that constitutively active receptors lose cooperative allosteric regulation in direct relation with their basal activity. The most constitutive mutants lost nearly all cooperativity and showed an increase of initial tracer binding, reflecting the ability of each protomer to bind with equal affinity. Allosteric interaction between the protomers takes place at the transmembrane domain. The allosteric message resulting from hormone binding to the ectodomain of one protomer travels 'downward' to its transmembrane domain, before affecting the transmembrane domain of the other protomer. This results in transmission of an 'upward' message lowering the binding affinity of the ectodomain of the second protomer. Our results demonstrate a direct relation between the conformational changes associated with activation of the transmembrane domain and the allosteric behaviour of glycoprotein hormone receptors dimers.

摘要

糖蛋白激素受体表现出强烈的负协同性。因此,在生理激素浓度下,单个激动剂结合到受体二聚体上。在这里,我们提供的证据表明,组成型激活的受体与其基础活性直接相关而失去协同变构调节。最组成型的突变体几乎失去了所有的协同性,并表现出初始示踪剂结合的增加,反映了每个单体以相等的亲和力结合的能力。单体之间的变构相互作用发生在跨膜域。从激素结合到一个单体的细胞外结构域的变构信息“向下”传递到其跨膜域,然后影响另一个单体的跨膜域。这导致传递“向上”的信息,降低第二个单体的细胞外结构域的结合亲和力。我们的结果表明,与跨膜域激活相关的构象变化与糖蛋白激素受体二聚体的变构行为之间存在直接关系。

相似文献

1
Evidence for activity-regulated hormone-binding cooperativity across glycoprotein hormone receptor homomers.活性调节的激素结合协同作用横跨糖蛋白激素受体同源体的证据。
Nat Commun. 2012;3:1007. doi: 10.1038/ncomms1991.
2
Specificity of cognate ligand-receptor interactions: fusion proteins of human chorionic gonadotropin and the heptahelical receptors for human luteinizing hormone, thyroid-stimulating hormone, and follicle-stimulating hormone.同源配体-受体相互作用的特异性:人绒毛膜促性腺激素与促黄体生成素、促甲状腺激素和促卵泡激素的七螺旋受体的融合蛋白
Endocrinology. 2003 Jan;144(1):129-37. doi: 10.1210/en.2002-220829.
3
A molecular dissection of the glycoprotein hormone receptors.糖蛋白激素受体的分子剖析
Trends Biochem Sci. 2004 Mar;29(3):119-26. doi: 10.1016/j.tibs.2004.01.006.
4
Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions.糖蛋白激素受体配体结合区域的结构预测及激素-受体相互作用的本质
Structure. 1995 Dec 15;3(12):1341-53. doi: 10.1016/s0969-2126(01)00272-6.
5
Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.糖蛋白激素受体:受体同二聚化与负协同性之间的联系。
EMBO J. 2005 Jun 1;24(11):1954-64. doi: 10.1038/sj.emboj.7600686. Epub 2005 May 12.
6
Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor.突变促性腺激素受体的细胞内滞留导致促卵泡激素受体的激素结合活性丧失,但促黄体生成素/绒毛膜促性腺激素受体的激素结合活性未丧失。
Mol Endocrinol. 1995 Dec;9(12):1727-36. doi: 10.1210/mend.9.12.8614409.
7
Towards understanding the glycoprotein hormone receptors.迈向对糖蛋白激素受体的理解。
Biochimie. 1991 Jan;73(1):109-20. doi: 10.1016/0300-9084(91)90083-d.
8
Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity.糖蛋白激素受体:富含亮氨酸重复序列中负责配体特异性的决定因素。
EMBO J. 2003 Jun 2;22(11):2692-703. doi: 10.1093/emboj/cdg260.
9
Allosteric Regulation of the Follicle-Stimulating Hormone Receptor.卵泡刺激素受体的变构调节。
Endocrinology. 2018 Jul 1;159(7):2704-2716. doi: 10.1210/en.2018-00317.
10
Differential responses of an invariant region in the ectodomain of three glycoprotein hormone receptors to mutagenesis and assay conditions.三种糖蛋白激素受体胞外域中一个恒定区域对诱变和检测条件的差异反应。
Endocrine. 2002 Nov;19(2):147-54. doi: 10.1385/ENDO:19:2:147.

引用本文的文献

1
Structure of an LGR dimer - an evolutionary predecessor of glycoprotein hormone receptors.LGR二聚体的结构——糖蛋白激素受体的进化前身。
bioRxiv. 2025 Jan 2:2024.12.31.630923. doi: 10.1101/2024.12.31.630923.
2
Highly-Sensitive In Vitro Bioassays for FSH, TSH, PTH, Kp, and OT in Addition to LH in Mouse Leydig Tumor Cell.在体外添加 LH 情况下,用于 FSH、TSH、PTH、Kp 和 OT 的高敏生物测定法在小鼠 Leydig 肿瘤细胞中的应用。
Int J Mol Sci. 2023 Jul 27;24(15):12047. doi: 10.3390/ijms241512047.
3
Crystal structure of LGR ligand α2/β5 from with implications for the evolution of glycoprotein hormones.

本文引用的文献

1
Crystal structure of the β2 adrenergic receptor-Gs protein complex.β2 肾上腺素能受体-Gs 蛋白复合物的晶体结构。
Nature. 2011 Jul 19;477(7366):549-55. doi: 10.1038/nature10361.
2
Occupancy of both sites on the thyrotropin (TSH) receptor dimer is necessary for phosphoinositide signaling.促甲状腺激素(TSH)受体二聚体上两个位点的占据对于磷酸肌醇信号转导是必需的。
FASEB J. 2011 Oct;25(10):3687-94. doi: 10.1096/fj.11-188961. Epub 2011 Jun 24.
3
The structural basis of agonist-induced activation in constitutively active rhodopsin.激动剂诱导的固有激活状态视紫红质激活的结构基础。
LGR 配体 α2/β5 的晶体结构,提示糖蛋白激素的进化。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2218630120. doi: 10.1073/pnas.2218630120. Epub 2022 Dec 27.
4
Human FSH Glycoform α-Subunit Asparagine Glycans: Major Glycan Structural Consistency, Minor Glycan Variation in Abundance.人促卵泡激素糖型 α 亚基天门冬酰胺聚糖:主要糖结构一致性,丰度上的次要糖变异。
Front Endocrinol (Lausanne). 2022 Oct 18;13:767661. doi: 10.3389/fendo.2022.767661. eCollection 2022.
5
Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion.甲状腺内正向和负反馈网络调节甲状腺激素的合成和分泌。
Front Endocrinol (Lausanne). 2022 Sep 15;13:992883. doi: 10.3389/fendo.2022.992883. eCollection 2022.
6
Expression and Characterization of Relaxin Family Peptide Receptor 1 Variants.松弛素家族肽受体1变体的表达与特性分析
Front Pharmacol. 2022 Jan 28;12:826112. doi: 10.3389/fphar.2021.826112. eCollection 2021.
7
Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.信号转导调控的结构复杂性和可塑性:黑素皮质素 4 受体。
Int J Mol Sci. 2020 Aug 10;21(16):5728. doi: 10.3390/ijms21165728.
8
Molecular and functional insights into gonadotropin hormone receptor dimerization and oligomerization.促性腺激素受体二聚化和寡聚化的分子及功能研究
Minerva Ginecol. 2018 Oct;70(5):539-548. doi: 10.23736/S0026-4784.18.04287-9. Epub 2018 Sep 13.
9
Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity.促甲状腺激素受体单克隆抗体可变区结构提供了对其反向激动剂活性潜在机制的深入了解。
Thyroid. 2018 Jul;28(7):933-940. doi: 10.1089/thy.2018.0176. Epub 2018 Jun 29.
10
Structural-Functional Features of the Thyrotropin Receptor: A Class A G-Protein-Coupled Receptor at Work.促甲状腺激素受体的结构功能特征:发挥作用的A类G蛋白偶联受体
Front Endocrinol (Lausanne). 2017 Apr 24;8:86. doi: 10.3389/fendo.2017.00086. eCollection 2017.
Nature. 2011 Mar 31;471(7340):656-60. doi: 10.1038/nature09795. Epub 2011 Mar 9.
4
G protein-coupled receptors: mutations and endocrine diseases.G 蛋白偶联受体:突变与内分泌疾病。
Nat Rev Endocrinol. 2011 Jun;7(6):362-72. doi: 10.1038/nrendo.2011.20. Epub 2011 Feb 8.
5
G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient.血清素 4 型受体二聚体对 G 蛋白的激活:开启两个前体更有效的证据。
J Biol Chem. 2011 Mar 25;286(12):9985-97. doi: 10.1074/jbc.M110.201939. Epub 2011 Jan 19.
6
Structure and function of an irreversible agonist-β(2) adrenoceptor complex.不可逆激动剂-β(2)肾上腺素能受体复合物的结构与功能。
Nature. 2011 Jan 13;469(7329):236-40. doi: 10.1038/nature09665.
7
Evidence that the thyroid-stimulating hormone (TSH) receptor transmembrane domain influences kinetics of TSH binding to the receptor ectodomain.证据表明,促甲状腺激素(TSH)受体跨膜域影响 TSH 与受体胞外域结合的动力学。
J Biol Chem. 2011 Feb 25;286(8):6219-24. doi: 10.1074/jbc.M110.211003. Epub 2010 Dec 28.
8
Class A GPCR heterodimers: evidence from binding studies.A 类 G 蛋白偶联受体二聚体:来自结合研究的证据。
Trends Pharmacol Sci. 2010 Nov;31(11):499-508. doi: 10.1016/j.tips.2010.08.003. Epub 2010 Oct 1.
9
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.时间分辨荧光共振能量转移(FRET)技术揭示了天然组织中 G 蛋白偶联受体配体的寡聚体。
Nat Chem Biol. 2010 Aug;6(8):587-94. doi: 10.1038/nchembio.396. Epub 2010 Jul 11.
10
Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.通过分子间合作在体内挽救有缺陷的 G 蛋白偶联受体功能。
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2319-24. doi: 10.1073/pnas.0906695106. Epub 2010 Jan 11.